Viewing data from:

NYSTATIN

ANDA

NYSTATIN | A203621 | PHARMACEUTICAL ASSOCIATES INC

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: NILSTAT(TE code: AA)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 3 NDCs

Highest NADAC/Unit

$0.1442

per ml

Lowest NADAC/Unit

$0.0592

per ml

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
00121086802NYSTATIN 100,000 UNIT/ML SUSP	$0.1442	ML	Generic	—	2026-06-17
00121104516NYSTATIN 100,000 UNIT/ML SUSP	$0.0592	ML	Generic	—	2026-06-17
00121086816NYSTATIN 100,000 UNIT/ML SUSP	$0.0592	ML	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 3 NDCs (3 FSS)

Lowest Price

$10.28

Highest Price

$95.99

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
00121-0868-02NYSTATIN 100000UNT/ML SUSP,ORAL	$10.28	FSS	Golden State Medical Supply, Inc.	06/14/2028
00121-0868-16NYSTATIN 100000UNT/ML SUSP,ORAL	$34.21	FSS	Golden State Medical Supply, Inc.	06/14/2028
00121-0868-50NYSTATIN 100000UNT/ML SUSP,ORAL	$95.99	FSS	Golden State Medical Supply, Inc.	06/14/2028

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain4 active DMFs5 inactive

4 active API suppliers hold Drug Master Files for this ingredient.

CENTRIENT PHARMACEUTICALS NETHERLANDS BVNYSTATIN

DMF 135231998

VUAB PHARMA ASNYSTATIN USP

DMF 140561999

ANTIBIOTICE SANYSTATIN

DMF 148132000

CONCORD BIOTECH LTDNYSTATIN USP

DMF 417912025

SHAOXING PHARMACEUTICAL FACTORYInactiveNYSTATIN

DMF 125571997

ER SQUIBB AND SONS INCInactiveNYSTATIN

DMF 132981998

BRISTOL MYERS SQUIBB COInactiveNYSTATIN

DMF 134411998

LEDERLE LABORATORIESInactiveNYSTATIN BULK POWDER

DMF 150282000

OLON SPAInactiveNYSTATIN

DMF 352252020

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 100,000 UNITS/ML

0 patents0 exclusivities▴

SUSPENSION;ORAL | Approved: Jan 7, 2016

No patent or exclusivity listings for this strength.